3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Classical hematology
1
Conditions
Lymphoma
26
Precursor Cell Lymphoblastic Leukemia-Lymphoma
24
Lymphoma, Large B-Cell, Diffuse
21
Lymphoma, Non-Hodgkin
19
Lymphoma, Mantle-Cell
17
Lymphoma, Follicular
16
Hodgkin Disease
15
Lymphoma, T-Cell, Cutaneous
13
Leukemia, Lymphocytic, Chronic, B-Cell
12
Mycosis Fungoides
11
Lymphoma, B-Cell, Marginal Zone
11
Leukemia, Myeloid, Acute
11
Burkitt Lymphoma
11
Sezary Syndrome
9
Lymphoma, Large-Cell, Anaplastic
8
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
7
Lymphoma, T-Cell
7
Lymphoma, Large-Cell, Immunoblastic
7
Immunoblastic Lymphadenopathy
7
Blast Crisis
7
Myeloproliferative Disorders
6
Lymphoma, Extranodal NK-T-Cell
6
Lymphoma, B-Cell
6
Leukemia
6
Waldenstrom Macroglobulinemia
5
Recurrence
5
Multiple Myeloma
5
Leukemia, Myelomonocytic, Chronic
5
Leukemia, Myeloid, Accelerated Phase
5
Congenital Abnormalities
5
Interventions
eltrombopag
3
Etoposide
3
Cytarabine
3
romiplostim
2
Platelet Transfusion
2
Lenalidomide
2
Filgrastim
2
Cyclosporine
2
Cyclophosphamide
2
sodium thiosulfate
1
siltuximab
1
pegfilgrastim
1
ofatumumab
1
fludarabine phosphate
1
etoposide phosphate
1
avatrombopag
1
alvocidib
1
Vorinostat
1
Vitamin E
1
Vincristine
1
Topotecan
1
Thioguanine
1
Surveys and Questionnaires
1
Rituximab
1
Ritonavir
1
Radiotherapy
1
Quality of Life
1
Prednisone
1
Peripheral Blood Stem Cell Transplantation
1
Methotrexate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Thrombocytopenia
×
Vorinostat
×
Lymphoid
×
Clear all
NCT01500538
2016-02-15
VEIL
Peter MacCallum Cancer Centre, Australia
Phase 2
Terminated
1 enrolled